Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.4%
5Y CAGR+33.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+31.4%/yr
vs +20.6%/yr prior
5Y CAGR
+33.7%/yr
Consistent
Acceleration
+10.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$23.69M+59.3%
2024$14.87M+16.1%
2023$12.81M+22.8%
2022$10.43M+37.0%
2021$7.61M+37.3%
2020$5.54M+54.1%
2019$3.60M-27.1%
2018$4.93M+3.5%
2017$4.76M-3.4%
2016$4.93M-